Archive for February 26th, 2010

Handmade In Denmark—BLAC

February 26th, 2010

blacBlac is a new innovative eyewear brand. Revolutionary designer eyewear for men made in carbon fibre and fibreglass with titanium strengthening. Blac is the world’s first adjustable carbon fibre frame. It is designed and handmade exclusively in Denmark by the renowned designer eyewear company BELLINGER A/S. The characteristics of carbon and fibreglass are its unique woven surface, an unusual lightness combined with great strength.

Every Blac frame is unique…
Blac is handmade in Denmark by our own specialized production team located in Aarhus, Denmark. The production process is new and innovative and is thus kept top secret. Patent has been applied for. Every Blac frame requires special attention and craftsmanship to secure the unique design of each frame. Each frame is custom made by hand for each individual customer with hinges, screws and end-tips being specially produced for our Blac frames. The carbon fibre and fibreglass frames in the Blac line are manufactured using the raw material directly in the process. No lacquer is attached providing each frame with a unique raw surface of the woven carbon fibre and fibreglass fabric.

blac.dk

Bionic Vision

February 26th, 2010

Blindness affects millions of people around the world. Whether it occurs as a result of an illness or accident, or someone was born blind, losing eyesight can be an extremely devastating thing to deal with. Over several years, a medical miracle known as bionic vision has shocked and surprised the medical community. The procedure generally consists of a very small camera that is attached to the optic nerve in the visual cortex, which is then attached to a stimulator on the retina. The entire device is held in place by a pair of glasses, which is attached to a small computer, which in turn sends signals that mimic sight directly to the patient’s brain.

A woman named Cheri Robertson is the 16th person to undergo the procedure for bionic vision. She lost her vision in a violent car accident at the age of 19 several years ago, and went completely blind. With the help of the procedure, she can now function much more efficiently than before. While her eyesight is not completely restored, she can now see outlines and basic images, unlike before the procedure. Currently, there are about one million blind adults in America, and this does not include children. Since there are so many people suffering from blindness, one may think this new miracle would be an automatic part of helping blind people see again. However, it is still fairly new and comes at a cost of anywhere from $20-$30,000.

There are many factors that doctors use to determine the best candidates for the bionic vision procedure. People like Cheri Robertson have had to travel to another country in order to have it performed, since it is not currently available in the United States.

Ultimately, the goal of bionic vision is to help blind adults be more independent and function in society, instead of feeling as if they are now doomed to stay inside or only do things with someone helping them. There are currently only a handful of people who have had the procedure, but that number is expected to increase as new technology surfaces.

bionicvision.org.au

Tura and Eschenbach Group Merge

February 26th, 2010

eschenbach

The Eschenbach Group of Nuremberg has acquired U.S. based eyewear player Tura. Tura has been active on both the U.S. and Canadian markets for more than 70 years as one of the top providers of eyeglass frames and sunglasses. Eschenbach has been marketing its frames and sunglasses in the United States since 2001 through its subsidiary BBH Eyewear Inc.. The addition of the Eschenbach collections to the Tura brand portfolio is expected to significantly strengthen joint sales of all product lines and accelerate growth at Tura, which will continue to operate as an autonomous company. Tura President John Weir and the current executive management team will remain unchanged, as will Tura’s sales network, distribution structure and support staff. The Eschenbach Group subsidiary, Eschenbach Optik of America, has advanced since 1983 to become the market leader for optical and electronic low vision products and will continue this focus in the United States. Barclays Private Equity has been supporting the Eschenbach Groups rigorous growth strategy since 2007 as a private equity investor. Confidentiality has been agreed as to the purchase price.

Founded in New York in 1938, Tura provides the U.S. and Canadian eyewear markets (a strong focus on the independent opticians, optometrists & ophthalmologists) with highquality frames and sunglasses. In addition to its own popular brands, such as Tura and Turaflex, the company also sells the Ted Baker, Lulu Guinness, Tourneau and Goldfinch brands under license. With its outstanding distribution network in the U.S. market and its successful management team, Tura is ideally positioned to implement the jointly defined growth strategy. Tura will prosper from the distribution of the TITANflex, Humphrey´s, Brendel, Marc O’Polo and Bogner Eyes collections that Eschenbach has been marketing in the United States.

This means that the Nuremberg-based Eschenbach Group will generate annual sales of just under $210 million dollars (USD) in 2010 with its high-quality eyeglass frames, sunglasses, vision aids, consumer optics and technical optics. The corporate group has developed at an above-average pace since Barclays Private Equity acquired a majority stake in Eschenbach in 2007.

“Following the acquisition of International Eyewear in the United Kingdom in 2008, our merger with Tura marks a major milestone on the road towards establishing a global presence in the eyewear market, over and above the growth opportunities offered by the American market,” explains Wolfgang Rebstock, Chief Executive Officer at Eschenbach Group.

Peter Schwind, head of the Eyewear Division at Eschenbach, adds:

“In acquiring Tura, we intend to more firmly anchor our product portfolio in North America, and further broaden the importance of our brands. Recent talks indicate that Eschenbach has thus additionally positioned itself as a candidate for international brand licenses.”

Tura President John Weir views the merger with Eschenbach as a tremendous opportunity for both companies.

“With the Eschenbach Group, we have found a partner who will support Tura’s independence over the long term. Together, we’ll be working to continue to tap into the enormous potential offered by the U.S. market.”

“We are delighted that we have once again been able to bring two companies together that complement each other so ideally. Two years ago, we set out at Eschenbach to work together with its management to support the Group’s strategic growth on a sustained basis. With two add-ons within merely two years, we are already very close to achieving that goal,” notes Michael H. Bork, Managing Director of Barclays Private Equity Germany.

eschenbach-optik.com

Glaucoma Eye Test Through the Eyelid

February 26th, 2010

diaton2

diaton1Diaton Tonometry is a revolutionary approach to measuring intraocular pressure (IOP) through the eyelid – no contact with the cornea, no anesthesia or sterilization is required. BiCOM’s pen-like, hand-held, portable device is perfect for measuring eye pressure and helps ophthalmologists and optometrists in diagnosis and prevention of blindness caused by glaucoma. This ophthalmic device is irreplaceable for mass glaucoma screenings.

Diaton Tonometer is intended for use by Inpatient & Outpatient Clinics such as Hospitals, Emergency Rooms, Nursing and Elderly Homes, General and Specialty Practitioners as well as Ophthalmologists and Optometrists.

Tonometer Diaton is the solution in the following cases when the use of other devices is problematic or impossible:

  • Mass prophylactic screening of patients
  • IOP control during clinical observation of glaucoma patients
  • Ortoclinostatical probe, as an additional test to diagnose glaucoma and during select the adequate hypotensive therapy
  • Ophthalmotone monitoring (even at night time)
  • IOP measuring during contact correction (lenses are not taken out)
  • IOP measuring in immobilized patients
  • IOP measuring in children
  • On patients with the following conditions: chronic conjunctivitis, cornea pathology, including keratitis, keratotone, cornea dimness, after penetrating keratoplastics, keratoprosthesis, laser refractive correction of the eyesight, high degree of ametropy, astigmatism
  • On patients with medicinal allergies
  • Lasik / LASEK / PRK (recent clinical trials have proved that Diaton is the only device that can be used for IOP measurement right after these surgeries)

Diaton tonometer is a perfect device for mass screenings for glaucoma for any age group. Undiagnosed and untreated, glaucoma can cause blindness. Glaucoma is the leading cause of blindness in all age groups – from babies to senior citizens. Everyone needs to get diagnosed to preserve eyesight.

tonometerdiaton.com